Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of fludarabine dose on outcome after allo-HSCT with reduced intensity conditioning for older patients with AML.
Dachy G, Labopin M, Socié G, Castilla-Llorente C, Forcade E, Blau IW, Ceballos P, Deconinck E, Burns D, Bulabois CE, Vrhovac R, Huynh A, Blaise D, Maertens J, Schroeder T, Bay JO, Savani B, Spyridonidis A, Ciceri F, Mohty M. Dachy G, et al. Among authors: castilla llorente c. Bone Marrow Transplant. 2025 Jun 19. doi: 10.1038/s41409-025-02614-1. Online ahead of print. Bone Marrow Transplant. 2025. PMID: 40537507
Gut microbiota modulation through Akkermansia spp. supplementation increases CAR-T cell potency.
Marcos-Kovandzic L, Avagliano M, Ben Khelil M, Srikanthan J, Abdallah R, Petrocelli V, Rengassamy J, Alfaro A, Bied M, Fidelle M, Ferrere G, Daillere R, Arbab A, Amine-Hneineh R, Pages A, Dartigues P, Ly P, Simon S, Durand S, Gottschlich A, Ginhoux F, Bleriot C, Liu P, Zhao L, Creusot L, Rolhion N, Kroemer G, Menger L, Kobold S, Castilla-Llorente C, Sokol H, Casola S, Pasolli E, Zitvogel L, Bigenwald C. Marcos-Kovandzic L, et al. Among authors: castilla llorente c. Cancer Discov. 2025 Jun 11. doi: 10.1158/2159-8290.CD-24-1230. Online ahead of print. Cancer Discov. 2025. PMID: 40498998
Challenging the Adverse Label: Diverse Outcomes of ELN 2022 Adverse Cytogenetic Subgroups in Acute Myeloid Leukemia Patients Allografted in First Remission: From EBMT ALWP.
Bazarbachi A, Galimard JE, Dalle IA, Socié G, Versluis J, Wu D, Eder M, Labussière-Wallet H, Yakoub-Agha I, Maertens J, Forcade E, Gedde-Dahl T, Choi G, Castilla-Llorente C, Baron F, Brissot E, Esteve J, Nagler A, Mohty M, Ciceri F. Bazarbachi A, et al. Among authors: castilla llorente c. Am J Hematol. 2025 May 30. doi: 10.1002/ajh.27726. Online ahead of print. Am J Hematol. 2025. PMID: 40445901
Improved outcomes over time in patients aged ≥60 years undergoing allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia in first complete remission: a large study by the EBMT acute leukemia working party.
Moukalled N, Ferhat AT, Bazarbachi A, Blaise D, Broers AEC, Castilla-Llorente C, Wagner-Drouet E, Halkes C, Schroeder T, Passweg J, Yakoub-Agha I, Dreger P, Kröger N, Fanin R, Gabellier L, Blau IW, Brissot E, Nagler A, Giebel S, Mohty M, Ciceri F. Moukalled N, et al. Among authors: castilla llorente c. Bone Marrow Transplant. 2025 May 28. doi: 10.1038/s41409-025-02630-1. Online ahead of print. Bone Marrow Transplant. 2025. PMID: 40437045
Allogeneic Hematopoietic Stem Cell Transplantation for Elderly Acute Lymphoblastic Leukemia Patients: A Registry Study From the Société Francophone de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC).
Chalandon Y, Devillier R, Boumendil A, Nguyen S, Bulabois CE, Ceballos P, Brissot E, Rubio MT, Labussière-Wallet H, Maertens J, Chevallier P, Maillard N, Poiré X, Castilla-Llorente C, Beguin Y, Cornillon J, Maury S, Marchand T, Daguindau E, Bay JO, Turlure P, Joris M, Menard AL, Bilger K, Guillerm G, François S, Bazarbachi A, Chantepie S, Lewalle P, Marçais A, Loschi M, Benakli M, Chauvet P, Forcade E, Huynh A, Robin M, Masouridi-Levrat S. Chalandon Y, et al. Among authors: castilla llorente c. Am J Hematol. 2025 Jul;100(7):1173-1184. doi: 10.1002/ajh.27701. Epub 2025 May 6. Am J Hematol. 2025. PMID: 40326583
The impact of ABO compatibility on allogeneic hematopoietic cell transplantation outcomes: a contemporary and comprehensive study from the transplant complications working party of the EBMT.
Güven M, Peczynski C, Boreland W, Blaise D, Peffault de Latour R, Yakoub-Agha I, Gedde-Dahl T, Salmenniemi U, Forcade E, Passweg J, Chevallier P, Sandrine L, Mielke S, Broers A, Ceballos P, Byrne J, Castilla-Llorente C, Maertens J, Huynh A, Cerretti R, Bulabois CE, van Gorkom G, Crawley C, Graham C, Mussetti A, Schoemans H, Penack O, Moiseev I, Peric Z. Güven M, et al. Among authors: castilla llorente c. Bone Marrow Transplant. 2025 Apr 17. doi: 10.1038/s41409-025-02580-8. Online ahead of print. Bone Marrow Transplant. 2025. PMID: 40246943
Efficacy and safety of belumosudil for treatment of cGVHD: multicenter retrospective analysis of the French cohort of the compassionate use program, on behalf of the French Society of Bone Marrow Transplantation and Cellular Therapy.
Michonneau D, Malard F, Le Grand S, Magro L, D'Aveni M, Tudesq JJ, Villate A, Meunier M, Maillard N, Castilla-Llorente C, Marçais A, Cabrera Q, Huynh A, Menard AL, Forcade E, Labussière-Wallet H, Raus N, Loschi M. Michonneau D, et al. Among authors: castilla llorente c. Bone Marrow Transplant. 2025 Jun;60(6):779-786. doi: 10.1038/s41409-025-02554-w. Epub 2025 Apr 1. Bone Marrow Transplant. 2025. PMID: 40169928 Free PMC article.
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
Scherlinger M, Nocturne G, Radic M, Launay D, Richez C, Bousso P, Forcade E, Meyer A, Jorgensen C, Bigenwald C, Cornec D, Sibilia J, Choquet S, Martin T, Belot A, Jouret M, Bitoun S, Amoura Z, Hermine O, Mariette X, Donnadieu E, Avouac J; Club for Innovative Immunotherapies in Immune-mediated Inflammatory diseases (C3I). Scherlinger M, et al. Lancet Rheumatol. 2025 Jun;7(6):e434-e447. doi: 10.1016/S2665-9913(24)00377-1. Epub 2025 Mar 26. Lancet Rheumatol. 2025. PMID: 40157379 Review.
Severe ICANS after CAR T-cell therapy and assessment of prevention with levetiracetam for seizure prophylaxis following CAR T-cell for DLBCL & PMBCL in Europe: a survey on behalf of the Cellular Therapy & Immunobiology Working Party (CTIWP) of the EBMT.
Angelillo P, Alarcon Tomas A, Campodonico E, Novak U, Gabellier L, Blau IW, Kwon M, Ram R, Forcade E, Besley C, Vucinic V, Kröger N, Corral LL, Vydra J, Ferrari S, von Tresckow B, Rubio MT, Hernani R, Sica S, Stölzel F, Rovira M, Wagner-Drouet E, Pérez-Simón JA, Castilla-Llorente C, Ferreri AJM, Hoogenboom JD, Sanchez Ortega I, Malard F, Kuball J, Ruggeri A. Angelillo P, et al. Among authors: castilla llorente c. Bone Marrow Transplant. 2025 Jan;60(1):100-102. doi: 10.1038/s41409-024-02451-8. Epub 2024 Oct 25. Bone Marrow Transplant. 2025. PMID: 39455896 No abstract available.
69 results